Daffy

Lazarex Cancer Foundation

Lazarex Cancer Foundation

Danville, CA 94526
Tax ID20-2562494

Want to make a donation using Daffy?

Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.

Payment method

Frequency

Amount

$USD
Daffy covers all ACH transaction fees so 100% of your donation goes to your favorite charities.

Do you work for Lazarex Cancer Foundation? Learn more here.

About this organization

Revenue

$3,289,365

Expenses

$4,988,333

Mission

At Lazarex Cancer Foundation, we strive to improve cancer health outcomes, FDA cancer clinical trial diversity and enrollment, and patient access to care by providing assistance with clinical trial navigation, reimbursing trial related travel costs, and partnering with at-risk communities to mobilize resources.

About

At Lazarex Cancer Foundation we improve the outcome of cancer care, giving hope, dignity and life to advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and engagement. We provide resources for cancer patients who have been told they have no other options, but who are not yet done with their journey in life and refuse to give up. - We help patients of all ages and walks of life, with all forms of cancer. - We help patients take advantage of medical breakthroughs today, because they may not have a tomorrow. - We believe that the size of a patient’s bank account should not stand between them and the choices they make or the treatments they need. - We present clinical trials as an alternative to hospice care for those who want to remain engaged in their fight against cancer. - We aspire to improve cancer survival rates through screenings and early detection, with a focus on the medically underserved to address health disparities.

Interesting data from their 2020 990 filing

The filing outlines the non-profit's goal as “Lazarex builds a bridge to hope, dignity, and life for cancer patients and their families. we provide financial assistance to defray the costs associated with patient participation in fda approved clinical trials.”.

When explaining its purpose, the activities were outlined as: “Lazarex builds a bridge to hope, dignity, and life for cancer patients and their families. we provide financial assistance to defray the costs associated with patient participation in fda approved clinical trials.”.

  • As per legal reporting requirements, the state of operation for the non-profit is CA.
  • The non-profit's address for 2020 is listed as PO BOX 741, DANVILLE, CA, 94526 in the filing.
  • As per the non-profit's form, they have 10 employees as of 2020.
  • Is not a private foundation.
  • Expenses are greater than $1,000,000.
  • Revenue is greater than $1,000,000.
  • Revenue less expenses is $783,046.
  • The organization has 10 independent voting members.
  • The organization was formed in 2006.
  • The organization pays $528,520 in salary, compensation, and benefits to its employees.
  • The organization pays $159,834 in fundraising expenses.

By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.